Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy ; volume:15 ; number:1 ; day:14 ; month:12 ; year:2020 ; pages:1-2 ; date:12.2020
Radiation oncology ; 15, Heft 1 (14.12.2020), 1-2, 12.2020
- Creator
-
Schaule, Jana
Kroeze, Stephanie G. C.
Blanck, Oliver
Stera, Susanne
Kahl, Klaus H.
Röder, Falk
Combs, Stephanie
Kaul, David
Claes, An
Schymalla, Markus M.
Adebahr, Sonja
Eckert, Franziska
Lohaus, Fabian
Abbasi-Senger, Nasrin
Henke, Guido
Szücs, Marcella
Geier, Michael
Sundahl, Nora
Bürgy, Daniel
Dummer, Reinhard
Guckenberger, Matthias
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01708-y
- URN
-
urn:nbn:de:101:1-2021012118173550655897
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schaule, Jana
- Kroeze, Stephanie G. C.
- Blanck, Oliver
- Stera, Susanne
- Kahl, Klaus H.
- Röder, Falk
- Combs, Stephanie
- Kaul, David
- Claes, An
- Schymalla, Markus M.
- Adebahr, Sonja
- Eckert, Franziska
- Lohaus, Fabian
- Abbasi-Senger, Nasrin
- Henke, Guido
- Szücs, Marcella
- Geier, Michael
- Sundahl, Nora
- Bürgy, Daniel
- Dummer, Reinhard
- Guckenberger, Matthias
- SpringerLink (Online service)
Other Objects (12)
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
![TGF-βs [TGF-Beta-s], PACAP und die Entwicklung der sympathoadrenalen Zelllinie](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
TGF-βs [TGF-Beta-s], PACAP und die Entwicklung der sympathoadrenalen Zelllinie
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Der Einfluss der PSMA-PET-Bildgebung für die Strahlentherapieplanung beim Prostatakarzinom
Modern Techniques of Radiation Therapy in the Treatment of Brain Tumors and Tumors of the Skull Base
Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma–a randomized trial
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)
Innovative Techniken in der Radiotherapie primärer und sekundärer Hirntumore
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
TGF-βs [TGF-Beta-s], PACAP und die Entwicklung der sympathoadrenalen Zelllinie
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Der Einfluss der PSMA-PET-Bildgebung für die Strahlentherapieplanung beim Prostatakarzinom
Modern Techniques of Radiation Therapy in the Treatment of Brain Tumors and Tumors of the Skull Base
Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma–a randomized trial
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)
Innovative Techniken in der Radiotherapie primärer und sekundärer Hirntumore
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma
TGF-βs [TGF-Beta-s], PACAP und die Entwicklung der sympathoadrenalen Zelllinie
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Der Einfluss der PSMA-PET-Bildgebung für die Strahlentherapieplanung beim Prostatakarzinom
Modern Techniques of Radiation Therapy in the Treatment of Brain Tumors and Tumors of the Skull Base
Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma–a randomized trial
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO)